【レポートの概要(一部)】
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Non Alcoholic Fatty Liver Disease (NAFLD) Overview 8
Therapeutics Development 9
Pipeline Products for Non Alcoholic Fatty Liver Disease (NAFLD) – Overview 9
Pipeline Products for Non Alcoholic Fatty Liver Disease (NAFLD) – Comparative Analysis 10
Non Alcoholic Fatty Liver Disease (NAFLD) – Therapeutics under Development by Companies 11
Non Alcoholic Fatty Liver Disease (NAFLD) – Therapeutics under Investigation by Universities/Institutes 13
Non Alcoholic Fatty Liver Disease (NAFLD) – Pipeline Products Glance 14
Late Stage Products 14
Clinical Stage Products 15
Early Stage Products 16
Non Alcoholic Fatty Liver Disease (NAFLD) – Products under Development by Companies 17
Non Alcoholic Fatty Liver Disease (NAFLD) – Products under Investigation by Universities/Institutes 18
Non Alcoholic Fatty Liver Disease (NAFLD) – Companies Involved in Therapeutics Development 19
Conatus Pharmaceuticals Inc. 19
Daewoong Pharmaceutical Co., Ltd. 20
Galmed International Ltd. 21
Kyorin Pharmaceutical Co., Ltd. 22
Metabolic Solutions Development Company, LLC 23
Novartis AG 24
Phenex Pharmaceuticals AG 25
Raptor Pharmaceuticals Corp. 26
TCM Biotech International Corp 27
Tobira Therapeutics, Inc. 28
Verva Pharmaceuticals Limited 29
Zafgen Inc. 30
Non Alcoholic Fatty Liver Disease (NAFLD) – Therapeutics Assessment 31
Assessment by Monotherapy Products 31
Assessment by Target 32
Assessment by Mechanism of Action 35
Assessment by Route of Administration 37
Assessment by Molecule Type 38
Drug Profiles 40
Antisense Oligonucleotides to Target ABHD6 for Gastrointestinal and Metabolic Disorders – Drug Profile 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
Aramchol – Drug Profile 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
cenicriviroc – Drug Profile 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
cysteamine DR – Drug Profile 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
DWP-10292 – Drug Profile 48
Product Description 48
Mechanism of Action 48
R&D Progress 48
emricasan – Drug Profile 49
Product Description 49
Mechanism of Action 49
R&D Progress 49
MAT-8800 – Drug Profile 51
Product Description 51
Mechanism of Action 51
R&D Progress 51
MB-12066 – Drug Profile 52
Product Description 52
Mechanism of Action 52
R&D Progress 52
methazolamide – Drug Profile 53
Product Description 53
Mechanism of Action 53
R&D Progress 53
MN-002 – Drug Profile 54
Product Description 54
Mechanism of Action 54
R&D Progress 54
MSDC-0602 – Drug Profile 55
Product Description 55
Mechanism of Action 55
R&D Progress 55
oltipraz – Drug Profile 56
Product Description 56
Mechanism of Action 56
R&D Progress 56
pradigastat sodium – Drug Profile 57
Product Description 57
Mechanism of Action 57
R&D Progress 57
Px-102 – Drug Profile 58
Product Description 58
Mechanism of Action 58
R&D Progress 58
Px-103 – Drug Profile 59
Product Description 59
Mechanism of Action 59
R&D Progress 59
Px-104 – Drug Profile 60
Product Description 60
Mechanism of Action 60
R&D Progress 60
Small Molecules to Activate AMPK for Fatty Liver Disease – Drug Profile 62
Product Description 62
Mechanism of Action 62
R&D Progress 62
TCM-606F – Drug Profile 63
Product Description 63
Mechanism of Action 63
R&D Progress 63
VVP-100-X – Drug Profile 64
Product Description 64
Mechanism of Action 64
R&D Progress 64
ZGN-839 – Drug Profile 65
Product Description 65
Mechanism of Action 65
R&D Progress 65
Non Alcoholic Fatty Liver Disease (NAFLD) – Recent Pipeline Updates 66
Non Alcoholic Fatty Liver Disease (NAFLD) – Dormant Projects 80
Non Alcoholic Fatty Liver Disease (NAFLD) – Product Development Milestones 81
Featured News & Press Releases 81
Apr 28, 2014: Galmed Pharmaceuticals Commences Patient Screening for Aramchol Pharmacokinetic and Food Effect Studies 81
Oct 31, 2012: Phenex Pharma Completes Phase I Studies With FXR-Agonist Px-102 81
Appendix 83
Methodology 83
Coverage 83
Secondary Research 83
Primary Research 83
Expert Panel Validation 83
Contact Us 84
Disclaimer 84
【レポート販売概要】
■ タイトル:非アルコール性脂肪性肝疾患(NAFLD)の治療薬パイプライン動向(2015年上半期版)■ 英文:Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H1 2015
■ 発行日:2015年1月22日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6052IDB
■ 調査対象地域:グローバル
- 個人および在宅医療部門におけるロボットの世界市場2018-2022About robotics in personal and homecare sector Robotics market in personal and homecare sector consist of companion and emotional therapy robots, that support end-user by offering entertainment and companionship. Technavio’s analysts forecast the Global robotics market in personal and homecare sector to grow at a CAGR of 77.18% during the period 2018-2022. Covered in this report The report covers …
- 世界のConfectionery市場におけるM&A動向(2014年2月)Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global confectionery market during February 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global confectionery market throughout the month. Additionally, the report provides an overview of all …
- 世界の睡眠時無呼吸症候群治療市場動向(~2020)Sleep apnea is a common disorder that occurs when a person’s breathing is interrupted during sleep. Sleep apnea is a chronic condition and often largely goes undiagnosed. Sleep apnea can be further differentiated into three types: obstructive sleep apnea, central sleep apnea, and complex/mixed sleep apnea. Obstructive sleep apnea occurs when the muscles relax during sleep, causing soft tissue in t …
- 医療用温度管理装置の世界市場:表面用装置、血管用装置、患者加温装置、患者クーリング装置The global market is expected to grow at a CAGR of 2.3% to reach USD 2,576.8 Million by 2020. Number of factors such as the worldwide development of technologically advanced temperature management systems, increase in aging population (which in turn is increasing the demand for age-related surgeries), and growing prevalence of cancer and cardiovascular diseases is propelling the growth of the glob …
- エレクトロニックセラミックス及び導電性セラミックスの世界市場予測(~2021年):モノリシックセラミック、セラミックマトリックス複合材料The global electronics ceramics & electrical ceramics market size is estimated to reach USD 11.98 Billion by 2021 at a CAGR of 4.89%. The global electronics ceramics & electrical ceramics market has witnessed significant growth in the recent years, and this growth is projected to persist in future. Electronics ceramics & electrical ceramics, due to their characteristic such as high-temperature sta …
- 世界のモバイル・ブロードバンド・モデム市場動向(2012-2016)TechNavio's analysts forecast the Global Mobile Broadband Modem Market to grow at a CAGR of 14.62 percent over the period 2012-2016. One of the key factors contributing to this market growth is the high adoption of mobile devices. The Global Mobile Broadband Modem Market has also been witnessing availability of 3G and 4G supporting modems. However, the increasing availability of mobile hotspot rou …
- エアロスタット(軽航空機)の世界市場2016-2020About Aerostat SystemsAn aerostat uses gases lighter than air such as hydrogen, helium, as well as hot air, which helps the aerostat to generate airlift. Aerostats include powered airships and unpowered balloons that are tethered to the ground. These are generally used for intelligence, surveillance, and reconnaissance (ISR) purposes by the military forces and for tourism and civilian observations …
- 熱管理の世界市場分析:製品別(ハードウェア、ソフトウェア、インタフェース、基板)、用途別(コンピュータ、消費者家電、テレコミュニケーション、自動車電子部品、再生可能エネルギー)、セグメント予測The global thermal management technologies market size is expected to reach USD 20.14 billion by 2024, according to a new report by Grand View Research, Inc. The industry is primarily driven by the growth in the emerging trend of miniaturization of electronic devices and components. Developments in the electronics industry have culminated in a considerable surge in the power densities, which have …
- 自動車遠隔診断の世界市場2016-2020About the Automotive Remote Diagnostics Market Technavio defines automotive remote diagnostics or remote vehicle diagnostics as a solution that enables automation of vehicle health and diagnosis using a wireless network. Vehicle health check refers to monitoring vehicle performance by continuously checking and assessing real time data of certain parameters. This process helps to identify any devia …
- 医療産業向けモバイルソリューションの世界市場:モバイル端末、モバイルアプリ、エンタープライズ・プラットフォームThe global healthcare mobility solutions market is expected to grow at a lucrative CAGR of 25% to 30% during the forecast period (2015 to 2020). Factors such as rising adoption of mobile computers such as smartphones and tablets in healthcare systems, rising focus on patient-centric applications, better cost efficiency of mobility solutions resulting in streamlined workflow, shortage of nursing st …
- 太陽光発電インバーターの世界市場2015Solar PV Inverter Market, Update 2015 - Segmentation, Market Size, Competitive Landscape, and Analysis to 2020 Summary “Solar PV Inverter Market, Update 2015 - Segmentation, Market Size, Competitive Landscape, and Analysis to 2020” is the latest report from GlobalData, the industry analysis specialists that offers information and a comprehensive understanding of the solar PV industry. The report a …
- 医療産業におけるLBS(位置情報サービス)の世界市場2016-2020About the Location-Based Services (LBS) in the healthcare industry The use of LBS in the healthcare industry can improve the operational efficiency of small and large hospitals worldwide. The growth of the market is driven by several factors such as the increased deployment of RTLS tags inside hospitals and the improvement in Wi-Fi and wireless land area network (WLAN) infrastructure of hospitals. …
- ナノ粒子ドラッグデリバリー市場及びパイプラインインサイトDrug delivery technologies currently occupy a significant position in the pharmaceutical industry. It has become so important that the mode of delivery of drugs has come to define the efficiency and marketability of those drugs. The pharmaceutical industry is witnessing a shift in the focus of the stakeholders towards newer systems of drug delivery in order to achieve efficient and safe transporta …
- Cangrelor(ACS/急性冠症候群):医薬品市場予測及び分析(~2023)Cangrelor (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Cangrelor (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023”. The current ACS market - primarily comprised of antithrombotics, antihypertensives, and statins - is flush with well-established standard-of-care therapies, many of which …
- とうもろこし粉の世界市場2017-2021ABSTRACTAbout Corn Flour The growing demand for Latin foods and the growing population of Hispanics are the prime factors driving the demand for corn four. In addition, the growth in the baking industry and food service segments and the growing popularity of corn-based snack products are the other drivers for the market growth. Established vendors are forming partnerships and strategic alliances, …